Predictors of morbidity and mortality after hepatectomy in elderly patients: Analysis of 7621 NSQIP patients

HPB

Volumn 16, Issue 5, 2014, Pages 459-468

  Tzeng, Ching Wei D ^a   Cooper, Amanda B ^a   Vauthey, Jean Nicolas ^a   Curley, Steven A ^a   Aloia, Thomas A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ABDOMINAL SURGERY; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DATA BASE; DIABETES MELLITUS; ELECTIVE SURGERY; FEMALE; GERIATRIC PATIENT; HEALTH CARE QUALITY; HUMAN; INTRAOPERATIVE PERIOD; LIVER RESECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PREDICTION; RISK FACTOR; SURGICAL MORTALITY; SURGICAL PATIENT; TREATMENT OUTCOME; VERY ELDERLY; AGE; COMPARATIVE STUDY; EPIDEMIOLOGY; INCIDENCE; MIDDLE AGED; PATIENT SELECTION; RISK ASSESSMENT; TIME; UNITED STATES;

AGE FACTORS; AGED; BLOOD TRANSFUSION; COMORBIDITY; FEMALE; HEPATECTOMY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OPERATIVE TIME; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84899644261     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12155     Document Type: Article

References (32)

1. Aloia TA, Fahy BN, Fischer CP, Jones SL, Duchini A, Galati J, et al. (2009) Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB 11: 510-515.
2. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al. (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236: 397-406; discussion 406-407.
3. Andres A, Toso C, Moldovan B, Schiffer E, Rubbia-Brandt L, Terraz S, et al. (2011) Complications of elective liver resections in a centre with low mortality: a simple score to predict morbidity. Arch Surg 146: 1246-1252.
4. Zimmitti G, Roses RE, Andreou A, Shindoh J, Curley SA, Aloia TA, et al. (2013) Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2628 consecutive resections. J Gastrointest Surg 17: 57-64; discussion 64-65.
5. Madoff DC, Abdalla EK, Vauthey JN,. (2005) Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 16: 779-790. (Pubitemid 40847898)
6. Kishi Y, Zorzi D, Contreras CM, Maru DM, Kopetz S, Ribero D, et al. (2010) Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17: 2870-2876.
7. Tzeng CW, Aloia TA,. (2013) Colorectal liver metastases. J Gastrointest Surg 17: 195-201.
8. Aloia TA, Zorzi D, Abdalla EK, Vauthey JN,. (2005) Two-surgeon technique for hepatic parenchymal transection of the non-cirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg 242: 172-177. (Pubitemid 41033432)
9. Farges O, Goutte N, Bendersky N, Falissard B,. (2012) Incidence and risks of liver resection: an all-inclusive French nationwide study. Ann Surg 256: 697-704; discussion 704-705.
10. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, et al. (2011) High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 29: 1083-1090.
11. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, et al. (2010) Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210: 934-941.
12. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD,. (2006) Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 93: 872-878. (Pubitemid 44035261)
13. Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, et al. (2008) 'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 25: 430-435.
14. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, et al. (2013) Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. doi: 10.1245/s10434-012-2864-7.
15. Nagano Y, Nojiri K, Matsuo K, Tanaka K, Togo S, Ike H, et al. (2005) The impact of advanced age on hepatic resection of colorectal liver metastases. J Am Coll Surg 201: 511-516. (Pubitemid 41393071)
16. Fong Y, Blumgart LH, Fortner JG, Brennan MF,. (1995) Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 222: 426-434; discussion 434-437.
17. Tsujita E, Utsunomiya T, Yamashita Y, Ohta M, Tagawa T, Matsuyama A, et al. (2012) Outcome of hepatectomy in hepatocellular carcinoma patients aged 80 years and older. Hepatogastroenterology 59: 1553-1555.
18. Kneuertz PJ, Pitt HA, Bilimoria KY, Smiley JP, Cohen ME, Ko CY, et al. (2012) Risk of morbidity and mortality following hepato-pancreato-biliary surgery. J Gastrointest Surg 16: 1727-1735.
19. Lightner AM, Glasgow RE, Jordan TH, Krassner AD, Way LW, Mulvihill SJ, et al. (2004) Pancreatic resection in the elderly. J Am Coll Surg 198: 697-706. (Pubitemid 38542897)
20. Al-Refaie WB, Parsons HM, Henderson WG, Jensen EH, Tuttle TM, Vickers SM, et al. (2010) Major cancer surgery in the elderly: results from the American College of Surgeons National Surgical Quality Improvement Program. Ann Surg 251: 311-318.
21. Strasberg SM, Hall BL,. (2011) Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg 213: 616-626.
22. Pitt HA, Kilbane M, Strasberg SM, Pawlik TM, Dixon E, Zyromski NJ, et al. (2009) ACS-NSQIP has the potential to create an HPB-NSQIP option. HPB 11: 405-413.
23. Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, et al. (2012) Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB 14: 506-513.
24. Dindo D, Demartines N, Clavien PA,. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213. (Pubitemid 38963009)
25. United States Census Bureau. (2011) Census Briefs: Age and Sex Composition 2010. Available at http://www.census.gov/prod/cen2010/briefs/ c2010br-03.pdf (last accessed 14 March 2013).
26. Siegel R, Naishadham D, Jemal A,. (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
27. Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, et al. (2013) Kinetic growth rate after portal vein embolization predicts post-hepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 216: 201-209.
28. Braga M, Gianotti L, Vignali A, Schmid A, Nespoli L, Di Carlo V,. (2005) Hospital resources consumed for surgical morbidity: effects of preoperative arginine and omega-3 fatty acid supplementation on costs. Nutrition 21: 1078-1086. (Pubitemid 41674585)
29. Braga M, Gianotti L, Vignali A, Carlo VD,. (2002) Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 132: 805-814. (Pubitemid 36307818)
30. Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, et al. (2007) Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 14: 3481-3491. (Pubitemid 350160107)
31. Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S, et al. (2012) Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215: 262-270.
32. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065-2072. (Pubitemid 46622116)